Vor biopharma to present at the barclays global healthcare conference

Cambridge, mass., march 05, 2021 (globe newswire) -- vor biopharma (nasdaq: vor), a cell therapy company pioneering engineered hematopoietic stem cell (ehsc) therapies combined with targeted therapies for the treatment of cancer, today announced that the company will be participating in the barclays global healthcare conference, which will take place virtually on march 9-11, 2021.
VOR Ratings Summary
VOR Quant Ranking